Intramolecular Etherification for HCV Protease Inhibitor Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of complex biologically active molecules, such as Compound 1, a potent inhibitor of the hepatitis C virus NS3/4A protease, is challenging due to the need for expensive catalysts and low throughput in ring-closing metathesis reactions, making current methods costly and inefficient.
Innovation Solution
A method involving an intramolecular etherification reaction to synthesize the macrocycle of Compound 1, eliminating the need for expensive catalysts and using low-cost starting materials, resulting in high throughput and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If ring-closing metathesis reaction is used to synthesize the macrocycle of Compound 1, then the macrocycle can be formed, but expensive catalysts and high catalyst loading are required, resulting in increased costs and low throughput
Solution Approach 1:
The patent replaces expensive, specialized ring-closing metathesis catalysts with common, inexpensive base chemicals (such as hydroxides or carbonates) that are readily available and do not require special handling or recovery processes. This substitution dramatically reduces catalyst costs while maintaining synthetic efficiency and throughput.
Solution Approach 2:
The patent fundamentally changes the reaction parameters by switching from catalytic conditions (requiring precious metals) to stoichiometric base conditions. This parameter change allows the use of abundant, cheap reagents instead of expensive catalysts, thereby reducing costs and improving productivity simultaneously.
2Ease of manufacture
If ring-closing metathesis reaction is used to synthesize the macrocycle of Compound 1, then the macrocycle can be formed, but expensive starting materials and high catalyst loading are required, resulting in increased costs
Solution Approach 1:
The patent eliminates the need for expensive catalysts by using inexpensive, readily available base chemicals as reagents. These bases are consumed in stoichiometric amounts rather than catalytic amounts, but their low cost and availability make the overall process more economical, eliminating the need for costly catalyst recovery and reduction processes.
3Productivity
If ring-closing metathesis reaction is used to synthesize the macrocycle of Compound 1, then the macrocycle can be formed, but dilute reaction conditions are required, resulting in low throughput
Solution Approach 1:
The patent changes the fundamental reaction conditions from dilute catalytic conditions to concentrated stoichiometric conditions. By using base chemicals in stoichiometric amounts rather than catalytic amounts, the reaction can proceed at higher concentrations, dramatically increasing throughput and productivity while reducing the time and resources required for reaction completion.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces synthesis costs and increases efficiency by eliminating the need for expensive catalysts, enabling the production of Compound 1 with improved enantio- and diastereoselectivity and broad genotype activity against HCV.
Implementation Method 1
A method involving an intramolecular etherification reaction to synthesize the macrocycle of Compound 1
Data Source
AI summary
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.